Neelima Vidula
尼利玛·维杜拉
MD
Assistant Professor of Medicine; Breast Medical Oncologist医学助理教授；乳腺内科肿瘤医生
👥Biography 个人简介
Breast oncologist at MGH focusing on TROP2-targeted ADCs, sacituzumab govitecan in TNBC, and translational research on TROP2 expression as a biomarker. Leads trials on novel ADC combinations in hard-to-treat breast cancer subtypes.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
TROP2-Targeted ADC Therapy in TNBC
Conducted translational studies on TROP2 expression heterogeneity in TNBC and led MGH-based trials evaluating sacituzumab govitecan combinations, advancing biomarker-driven selection for TROP2-directed therapy.
Representative Works 代表性著作
TROP2 Expression and Response to Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
npj Breast Cancer (2023)
Investigated TROP2 protein expression levels as predictive biomarkers for sacituzumab govitecan efficacy in mTNBC patients.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 尼利玛·维杜拉 的研究动态
Follow Neelima Vidula's research updates
留下邮箱，当我们发布与 Neelima Vidula（Massachusetts General Hospital, Harvard Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment